Medicines Co. (MDCO) Reports Q2 EPS of $2.51
Tweet
Share
E-mail
Get Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Income before income taxes: -86.2M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Income before income taxes: -86.2M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q2 EPS of $2.51,may not compare to the analyst estimate of ($1.16). Revenue for the quarter came in at $54.7 million versus the consensus estimate of $41.93 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
- Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
